Applied DNA Sciences Inc (APDN) News
Filter APDN News Items
APDN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APDN News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest APDN News From Around the Web
Below are the latest news stories about APPLIED DNA SCIENCES INC that investors may wish to consider to help them evaluate APDN as an investment opportunity.
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates- Signals Start of New Commercialization Phase for LineaRx Subsidiary - - Company Negotiating GMP Supply Agreement - - Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE / January 10, 2025 /Applied DNA Sciences, Inc. ... |
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy CarterApplied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it has rescheduled its Investor Update call to Thursday, February 13, 2025, to coincide ... |
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA- Regulatory Approval Showcases Clinical Advancement of Linea DNA™ as a Rapid and Effective Means of Producing CAR-T cell Therapies - STONY BROOK, NY / ACCESSWIRE / December 18, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ... |
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue EstimatesApplied DNA Sciences (APDN) delivered earnings and revenue surprises of 3.03% and 1.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
Applied DNA Sciences: Fiscal Q4 Earnings SnapshotThe Stony Brook, New York-based company said it had a loss of 32 cents per share. The DNA-based security technology company posted revenue of $813,100 in the period. Its adjusted revenue was $813,000. |
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic MedicinesApplied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today reported financial results for its fourth quarter and fiscal year ended September 30, 2024. An update on the buildout of the Company's ... |
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-outApplied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market ... |
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private PlacementSTONY BROOK, NY / ACCESSWIRE / October 30, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a registered direct offering and concurrent private ... |
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16STONY BROOK, NY / ACCESSWIRE / October 15, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in ... |
Applied DNA Sciences Inc (APDN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines ...Despite a challenging quarter with revenue declines, Applied DNA Sciences Inc (APDN) is poised for future growth through strategic partnerships and new service launches. |